Autres langues Telix Pharmaceuticals Limited

Actions

TLX

AU000000TLX2

Recherche biotechnologique et médicale

Temps Différé Australian S.E. 04:55:39 13/10/2026			Varia. 5j.	Varia. 1 janv.
15,75 ^AUD	-3,37%		+2,14%	+40,54%

09/10	Profound Medical et Telix Pharmaceuticals concluent un accord de formation sur la prise en charge de la prostate	MT
09/10	Profound Medical Corp. et Telix Pharmaceuticals concluent un accord de formation conjointe pour faire progresser la prise en charge de la prostate fondée sur le PSMA	CI

Autres langues

09/10	Profound Medical, Telix Pharmaceuticals Enter Prostate-Care Education Agreement
09/10	Profound Medical Corp. and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
07/10	Australian Shares Flat; Telix Pharmaceuticals Launches US Commercial Availability of Brain Cancer Imaging Drug
06/10	Telix Pharmaceuticals Launches US Commercial Availability of Brain Cancer Imaging Drug
06/10	Telix Pharmaceuticals Limited Announces First Patients Dosed With FDA-Approved Brain Cancer Imaging Drug Pixclara
06/10	Telix Doses First US Patients With FDA-Approved Brain Cancer Imaging Drug
06/10	Telix Pharmaceuticals : First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara (floretyrosine F 18)
06/10	First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
04/10	Telix Pharmaceuticals : Notification of cessation of securities - TLX
30/09	Telix Gets FDA Fast Track Status for Prostate Cancer Imaging System
30/09	Telix Pharmaceuticals Limited Receives FDA Fast Track Designation For BiPASS Pre-Biopsy Prostate Cancer Imaging
30/09	Telix Pharmaceuticals Gets US Fast-Track Designation for Pre-Biopsy Prostate Cancer Imaging Program
30/09	Telix Pharmaceuticals : Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging
22/09	ASX Preview: Australian Shares to Rise as Oil Prices Retreat; Telix Pharmaceuticals Receives ASX Waivers on Share Issuance Timing for Acquisition Consideration
22/09	Telix Pharmaceuticals Receives ASX Waivers on Share Issuance Timing for Acquisition Consideration
21/09	Telix to Buy Germany's ITM Isotope in Deal Worth Up to $2.35 Billion
21/09	Telix Pharmaceuticals Limited agreed to acquire ITM Isotope Technologies Munich SE for $2.3 billion .
21/09	Telix to Acquire Germany's ITM for $1.65 Billion
21/09	Australian shares end flat as miners offset gains in banks
21/09	MÄRKTE ASIEN/Freundlich - Sehr feste Samsung-Aktie treibt Kospi an
21/09	Australian Shares Flat; Telix Pharmaceuticals to Acquire German Radiopharmaceutical Biotechnology Company for Initial $1.65 Billion Payment
21/09	MÄRKTE ASIEN/Aktien freundlich - Ruhetag in Tokio - Ölpreis fällt weiter
21/09	MÄTKTE ASIEN/Aktien freundlich - Ruhetag in Tokio - Ölpreis fällt weiter
21/09	Telix Pharmaceuticals to Acquire German Radiopharmaceutical Biotechnology Company for Initial $1.65 Billion Payment, Shares Fall 3%
21/09	Australian shares edge lower as banks and miners drag